Revenue Summary of Pulike Biological Engineering, Inc.

Pulike Biological Engineering, Inc.'s latest annual revenue in 2023 was 1.25 Billion CNY , up 2.01% from previous year.
Pulike Biological Engineering, Inc.'s latest quarterly revenue in 2024 Q3 was 274.27 Million CNY , up 14.33% from previous quarter.
Pulike Biological Engineering, Inc. reported a annual revenue of 1.22 Billion CNY in annual revenue 2022, up 11.78% from previous year.
Pulike Biological Engineering, Inc. reported a annual revenue of 1.09 Billion CNY in annual revenue 2021, up 18.31% from previous year.
Pulike Biological Engineering, Inc. reported a quarterly revenue of 231.54 Million CNY for 2024 Q1, down -28.57% from previous quarter.
Pulike Biological Engineering, Inc. reported a quarterly revenue of 243.66 Million CNY for 2024 Q2, up 5.23% from previous quarter.

Annual Revenue Chart of Pulike Biological Engineering, Inc. (2023 - 2009)

Historical Annual Revenue of Pulike Biological Engineering, Inc. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	1.25 Billion CNY	2.01%
2022	1.22 Billion CNY	11.78%
2021	1.09 Billion CNY	18.31%
2020	928.51 Million CNY	40.01%
2019	663.19 Million CNY	9.07%
2018	608.05 Million CNY	14.75%
2017	529.89 Million CNY	-9.12%
2016	583.1 Million CNY	21.95%
2015	478.13 Million CNY	0.51%
2014	475.68 Million CNY	0.76%
2013	472.08 Million CNY	13.07%
2012	417.52 Million CNY	1.19%
2011	412.62 Million CNY	41.14%
2010	292.35 Million CNY	9.73%
2009	266.43 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	274.27 Million CNY	14.33%
2024 Q1	231.54 Million CNY	-28.57%
2024 Q2	243.66 Million CNY	5.23%
2023 Q2	308.93 Million CNY	1.08%
2023 Q4	324.14 Million CNY	3.24%
2023 FY	1.25 Billion CNY	2.01%
2023 Q3	313.96 Million CNY	1.63%
2023 Q1	305.64 Million CNY	-24.03%
2022 Q3	313 Million CNY	17.05%
2022 FY	1.22 Billion CNY	11.78%
2022 Q4	402.3 Million CNY	28.53%
2022 Q1	245.29 Million CNY	-11.62%
2022 Q2	267.41 Million CNY	9.02%
2021 Q4	277.54 Million CNY	14.79%
2021 FY	1.09 Billion CNY	18.31%
2021 Q1	308.68 Million CNY	9.82%
2021 Q3	241.78 Million CNY	-10.63%
2021 Q2	270.54 Million CNY	-12.36%
2020 Q2	228.6 Million CNY	18.35%
2020 Q1	193.15 Million CNY	0.47%
2020 FY	928.51 Million CNY	40.01%
2020 Q3	225.67 Million CNY	-1.28%
2020 Q4	281.07 Million CNY	24.55%
2019 Q1	147.3 Million CNY	-16.82%
2019 FY	663.19 Million CNY	9.07%
2019 Q3	151.35 Million CNY	-12.14%
2019 Q4	192.25 Million CNY	27.02%
2019 Q2	172.27 Million CNY	16.95%
2018 Q1	143.82 Million CNY	-3.33%
2018 FY	608.05 Million CNY	14.75%
2018 Q3	145.67 Million CNY	2.97%
2018 Q2	141.46 Million CNY	-1.63%
2018 Q4	177.09 Million CNY	21.58%
2017 Q4	148.78 Million CNY	21.11%
2017 FY	529.89 Million CNY	-9.12%
2017 Q3	122.84 Million CNY	-2.53%
2017 Q2	126.03 Million CNY	-4.68%
2017 Q1	132.22 Million CNY	-15.41%
2016 Q2	133.19 Million CNY	14.29%
2016 FY	583.1 Million CNY	21.95%
2016 Q4	156.3 Million CNY	-11.71%
2016 Q3	177.05 Million CNY	32.92%
2016 Q1	116.54 Million CNY	0.11%
2015 FY	478.13 Million CNY	0.51%
2015 Q4	116.41 Million CNY	-15.86%
2015 Q3	138.35 Million CNY	47.58%
2015 Q2	93.75 Million CNY	-27.67%
2015 Q1	129.61 Million CNY	23.03%
2014 Q1	123.8 Million CNY	0.0%
2014 Q4	105.35 Million CNY	-33.07%
2014 Q3	157.39 Million CNY	76.59%
2014 Q2	89.12 Million CNY	-28.01%
2014 FY	475.68 Million CNY	0.76%
2013 FY	472.08 Million CNY	13.07%
2012 FY	417.52 Million CNY	1.19%
2011 FY	412.62 Million CNY	41.14%
2010 FY	292.35 Million CNY	9.73%
2009 FY	266.43 Million CNY	0.0%

Peer Revenue Comparison of Pulike Biological Engineering, Inc.

Name	Revenue	Revenue Difference
Beijing Tiantan Biological Products Co., Ltd.	5.18 Billion CNY	75.819%
JiangSu WuZhong Pharmaceutical Development Co., Ltd.	2.22 Billion CNY	43.72%
Jinyu Bio-technology Co., Ltd.	1.59 Billion CNY	21.62%
Vcanbio Cell & Gene Engineering Corp., Ltd	1.58 Billion CNY	21.201%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	17.28 Billion CNY	92.751%
Zhejiang Ausun Pharmaceutical Co., Ltd.	816.76 Million CNY	-53.373%
DaShenLin Pharmaceutical Group Co., Ltd.	24.43 Billion CNY	94.874%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	5.47 Billion CNY	77.128%
GuiZhou SanLi Pharmaceutical Co.,Ltd	1.61 Billion CNY	22.596%
Beijing Konruns Pharmaceutical Co.,Ltd.	920.01 Million CNY	-36.161%
Shanghai Hile Bio-Technology Co., Ltd.	240.72 Million CNY	-420.388%
Qingdao Vland Biotech INC.	1.18 Billion CNY	-5.355%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.	784.34 Million CNY	-59.712%
Aurisco Pharmaceutical Co.,Ltd.	1.26 Billion CNY	0.779%
Zhejiang East Asia Pharmaceutical Co., Ltd.	1.35 Billion CNY	7.649%
Hainan Huluwa Pharmaceutical Group Co., Ltd.	1.9 Billion CNY	34.248%
Mabwell (Shanghai) Bioscience Co., Ltd.	127.68 Million CNY	-881.069%
Beijing Hotgen Biotech Co., Ltd.	541.25 Million CNY	-131.444%
Assure Tech (Hangzhou) Co., Ltd.	503.35 Million CNY	-148.868%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.	1.02 Billion CNY	-22.054%
Cabio Biotech (Wuhan) Co., Ltd.	443.8 Million CNY	-182.263%
Shanghai Shen Lian Biomedical Corporation	301.48 Million CNY	-315.505%
Nanjing Vazyme Biotech Co., Ltd.	1.28 Billion CNY	2.406%
Shandong Kexing Bioproducts Co,.Ltd	1.25 Billion CNY	0.504%
Shanghai Junshi Biosciences Co., Ltd.	1.48 Billion CNY	15.521%
Shanghai Model Organisms Center, Inc.	366.54 Million CNY	-241.754%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	385.41 Million CNY	-225.024%
Xiamen Amoytop Biotech Co., Ltd.	2.1 Billion CNY	40.357%
Novogene Co., Ltd.	2 Billion CNY	37.431%
Shanghai ZJ Bio-Tech Co., Ltd.	268.13 Million CNY	-367.185%
Chengdu Olymvax Biopharmaceuticals Inc.	496.11 Million CNY	-152.499%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	1.01 Billion CNY	-23.536%
Shanghai Haohai Biological Technology Co., Ltd.	2.63 Billion CNY	52.458%
Jiangsu Bioperfectus Technologies Co., Ltd.	403.17 Million CNY	-210.704%
Jiangsu Aidea Pharmaceutical Co., Ltd.	411.32 Million CNY	-204.547%
Chengdu Easton Biopharmaceuticals Co., Ltd.	1.11 Billion CNY	-12.136%
Sinocelltech Group Limited	1.88 Billion CNY	33.627%
Wuhan Keqian Biology Co.,Ltd	1.06 Billion CNY	-17.726%
Shanghai Allist Pharmaceuticals Co., Ltd.	1.99 Billion CNY	37.1%
Anhui Huaheng Biotechnology Co., Ltd.	1.93 Billion CNY	35.37%
Youcare Pharmaceutical Group Co., Ltd.	4.19 Billion CNY	70.148%
Jiangsu gdk Biotechnology Co., Ltd.	134.59 Million CNY	-830.738%
Beijing Kawin Technology Share-Holding Co., Ltd.	1.41 Billion CNY	11.283%
Hangzhou Biotest Biotech Co.,Ltd.	442.11 Million CNY	-183.344%

Global Stocks Search

Pulike Biological Engineering, Inc. (603566.SS)

Revenue Summary of Pulike Biological Engineering, Inc.

Annual Revenue Chart of Pulike Biological Engineering, Inc. (2023 - 2009)

Historical Annual Revenue of Pulike Biological Engineering, Inc. (2023 - 2009)

Peer Revenue Comparison of Pulike Biological Engineering, Inc.